VOLUME 34 · ISSUE 5 · MAY 2022
Visit AAN.com/Covid19 for the latest pandemic information and resources to support you and your crucial work.
MAY 26 IS EARLY REGISTRATION DEADLINE FOR NEW SUMMER CONFERENCE Autoimmune Neurology and Neurology Year in Review Secure your early registration savings by May 26 for the new AAN-hosted Summer Conference: Autoimmune Neurology and Neurology Year in Review coming this July 15 through 16 to the San Francisco Marriott Marquis. Those seeking the latest updates in the science and education of autoimmune neurology—one of the most rapidly evolving fields in modern neurology—won’t want to miss this first-of-its-kind conference opportunity to learn through a variety of styles including didactic lectures, hands-on experiences, case-based presentations, and more.
July 15–16, San Francisco
Continued on page 11
›
COVID-19 and Safety
Because of our commitment to creating a safe and healthy environment for participants, all in-person attendees, exhibitors, press personnel, guests, and staff must complete the COVID-19 vaccination process with an acceptable vaccine and booster, if eligible, a minimum of seven days prior to the event, provide verification of full COVID-19 vaccination status, and wear a mask indoors.
New Neurology: Education Journal Launched The AAN will publish a new journal—Neurology ® Education— to “be a premier peer-reviewed journal in the field of neurologic and neuroscience education research” and seeks submissions of papers on these topics. The mission of Neurology: Education is to publish original research articles, reviews, and editorials on evidence-based teaching methods and curriculum innovations, and to provide the academic community with a forum to exchange ideas that enhance teaching and training in neurology and neuroscience. Continued on page 10
6
AAN Issues Position Statement on Neuropalliative Care
›
Apply by May 18 for AAN Leadership Development Opportunities Now’s the time to invest in yourself and your career! Applications are open for three of the AAN’s all-expensespaid leadership development programs. These intensive and rewarding programs incorporate executive leadership education, collaboration with peers on a group project, 1:1 leadership coaching, and mentoring opportunities in the field of neurology. The value of great leadership is more important than ever in today’s challenging health care environment and
12 'Great Neuro Reunion'
Is Celebrated in Seattle
Continued on page 23
15 CMS Finalizes Limited
Coverage of Aducanumab
›
AANnews · May 2022
May Highlights The Mission of the AAN is to promote the highest quality patient-centered neurologic care and enhance member career satisfaction. The Vision of the AAN is to be indispensable to our members. Contact Information American Academy of Neurology 201 Chicago Avenue Minneapolis, MN 55415 Phone: (800) 879-1960 (toll free) (612) 928-6000 (international) Email:
memberservices@aan.com
Website: AAN.com For advertising rates, contact: Michael J. O’Brien II Account/Relationship Manager Wolters Kluwer Phone: (978) 578-4514 Email:
Michael.Obrien @wolterskluwer.com
07
Why Do Members Use AAN Neurology Compensation and Productivity Data?
09
Peers Provide Expert Answers to Practice Questions
They use it for “determining compensation ranges.” And “to calculate FTE values,” “be competitive,” and “be more successful in recruiting.” Because it’s “superior and more powerful” than other available data.
The practice@aan.com email inbox is an efficient way to reach staff and member expertise on practice related topics such as payers, MIPS/MACRA, coding, and practice management.
21
Leadership Program Opens Doors to Engagement
When asked about his experience with the AAN’s Emerging Leaders Program, 2017 graduate Beau Nakamoto, MD, PhD, MBA, FAAN, is quick to respond that “the biggest impact it had was that it opened the door to engage with the AAN and its members.”
AAN Chief Executive Officer: Mary E. Post, MBA, CAE
Editor-in-Chief: Melissa W. Ko, MD, FAAN, CPE Managing Editor: Angela M. Babb, MS, CAE, APR Editor: Tim Streeter Writers: Ryan Knoke and Sarah Parsons Designer: Siu Lee Email: aannews@aan.com AANnews® is published monthly by the American Academy of Neurology for its 38,000 members worldwide. Access this magazine and other AAN publications online at AAN.com. The American Academy of Neurology ’s registered trademarks and service marks are registered in the United States and various other countries around the world. “American Brain Foundation” is a registered service mark of the American Brain Foundation and is registered in the United States.
News Briefs AAN in the News The 2022 AAN Annual Meeting received plenty of great news coverage from journalists who covered abstracts presented at this year’s meeting. A preliminary study presented at the Annual Meeting that found owning a pet may be linked to slower cognitive decline was picked up by CNN, People, CNBC, and more than 500 national and international news outlets. A preliminary study linking tic severity with social media use for teens and young adults during the COVID-19 pandemic was mentioned by Daily Mail, Yahoo! News, and U.S. News & World Report. And a preliminary study showing that a ketogenic diet may improve the quality of life in people with multiple sclerosis was covered by Insider, UPI, MSN, and more.
The inclusion of advertisements and/or promotions of Sponsors and other Internet sites or resources that offer content, goods, or services on the Website does not imply endorsement of the advertised/promoted products or services by AAN.
PLEASE RECYCLE POLYBAG WHERE #5 PLASTIC IS ACCEPTED
Annual Meeting See You Next Year! Learn more about all our upcoming conferences at AAN.com/events/upcoming-events
Annual Meeting Boston • April 22 –28
PRESIDENT'S COLUMN Neurologists Lead Grassroots Activist Campaigns to Help Ukraine On February 24, the entire free world watched in horror as Russia invaded Ukraine. Since then, many civilians have been killed, homes, hospitals, and shelters have been demolished, and there is no end in sight. Like many of you, I have been awed by the bravery of those who stayed behind to protect their nation and its citizens, including health care professionals who remained to treat their existing patients and the casualties they knew would inevitably follow. Two days after the bombing and shelling began, I discovered that the American Academy of Neurology had almost three dozen members in the region. I was soon able to connect with three women (Dispatches from Ukrainian Neurologists: ‘We Need Medicines for Our Patients and Bandrivska Peace in Our Country,’ Neurology Today ®, March 3, 2022) and hear their heartbreaking stories. Each felt a responsibility to continue to care for neurologic patients despite overwhelming risks to their own safety. Among them, 24-year-old neurologist Solomiia Bandrivska, MD, who had been in practice but a month, vowed never to leave, and has continued to send me updates. A recent post was a screenshot of her ePoster acceptance by the European Academy of Neurology with an invitation to the 8th EAN conference in Vienna in June, a reflection of academic pursuits in times of normalcy before war. Prior messages over the past weeks had been selfies in scrubs, and short descriptions of living in the hospital 24/7, enduring long, exhausting days. While some members of our organization are working around the clock on the medical front lines of Ukraine, others are volunteering here in the United States and abroad, and their accomplishments have been extraordinary. AAN member Svetlana Faktorovich, MD, an attending neurologist Faktorovich and electrophysiologist at the Marcus Neuroscience Institute at Boca Raton Regional Hospital in Florida, immigrated from Kyiv as a child. Over the initial days of war, she realized that she needed to do something proactively to alleviate the anguish gripping her while watching the destruction of her homeland. When she came across a post from the Ukrainian League Against Epilepsy noting the critical need for anti-seizure medication (ASM) on the Women in Neurology Group page on Facebook, she began to raise money with the goal of contributing to this cause. She asked her hospital if she could purchase medications wholesale and with its help was able to start making shipments of ASM to the region. Upon confirmation of her first successful delivery into Lviv, Dr. Faktorovich set up a nonprofit (donate.brrh.com/ukrainehumanitarian-aid) through her hospital and expanded her list of purchases to include critical medication, certified trauma
4
AANnews • May 2022
kits, sleeping bags, and other supplies. Avitzur Together with Bosnian war survivor Senada Azdem, she is now actively raising funds for their next cargo. Through their collaboration with two nonprofit organizations, the Polish American Medical Society (zlpchicago.org) and the Global Empowerment Mission (globalempowermentmission.org), they are able to send shipments into Ukraine where they are needed most. Dr. Faktorovich has also enlisted commitments from other US neurologists for future telehealth services, having recruited about two dozen Russian- and Ukrainian-speaking neurologist volunteers to date, among many other English speakers. Within days of the Russian invasion, Aris Hadjinicolaou, MD, FRCPC, FAAP, current Boston Children’s hospital clinical neurophysiology fellow, received a request from Ukrainian pediatric epileptologist Olha Tychkivska, MD, with whom he completed epilepsy training at the Toronto Hadjinicolaou Hospital for Sick Children, to help her draft an appeal from the Ukrainian League Against Epilepsy. The letter, which later inspired Dr. Faktorovich, included the concern that sudden stoppage of ASM could have catastrophic consequences for patients. Many NGOs and governmental agencies had been working on critical access to food, shelter, medical supplies, and medications, but ASM had not been prioritized. What happened next is so extraordinary that I decided to chronicle it in a Neurology Today Q&A (https://bit.ly/3LqOQ2l) with AAN member Agnieszka Kielian, MD, a fellow in pediatric stroke and neurocritical care at Boston Children’s Hospital. It is a stunning example of grassroots activism, the impact of neurology networks, and the successes borne of a growing coalition of determined and innovative neurologists. AAN member Yuliya Snyder, MD, who was born in Kharkiv and attended medical school and residency there, currently works as a child neurologist at Rochester Regional Health in New York. Since my interview with her for Neurology Today (https://bit.ly/3Ccvj2v), she has used her Snyder close contacts in the region to reach an official from the Ministry of Health of Ukraine who provided her with a list of needed medical supplies and medications. Dr. Snyder has also been in touch
with other organizations and individuals in the US and abroad, and like the other volunteers, has learned that the logistics of humanitarian aid delivery have been challenging. Most of the infrastructure has been shut down, and there was little to begin with prior to the war. Much of the work is currently being done by single volunteers who are risking their lives driving humanitarian aid from Poland to Ukraine, Dr. Snyder said. Together with University of Rochester Medical Center/Golisano Children’s Hospital child neurologist and neurogeneticist Alexander R. Paciorkowski, MD, she has also launched a GoFundMe (gofund.me/b932f5dd) page in order to raise funds to organize the delivery of needed medical supplies directly to physician colleagues in Ukraine in collaboration with the Ukrainian Ministry of Health. In 2008, James C. Johnston, MD, JD, FAAN, helped found the partnership GlobalNeurology, serving Ethiopia and other regions. In 2009, he established an affiliate 501(c)(3) nonprofit, Global NeuroCare, which handles their charity work. It is dedicated to improving neurologic care for vulnerable populations, whether in developing regions or those impacted by disaster or conflict. The organization has been accredited by the World Health Organization and holds Special Consultative Status with the United Nations (UN) Economic and Social Council, which allows it to provide expert analysis on neurologic issues, implement and monitor international agreements, present written and oral statements at UN meetings, and serve as a delegate at the UN sessions to advance its goals and objectives. Its latest focus is to help Ukraine. It has partnered with Meest (us.meest.com) to fly supplies to Poland and has arranged for trusted contacts to transport and deliver shipments into Ukraine. Additionally, one of his on-site colleagues will coordinate help which may include telemedicine although right now acute trauma care is most urgently needed. Dr. Johnston recommends sending equipment donations to RazomforUkraine.org as it, along with many local Ukrainian societies, has lists of the most essential needs or can earmark donations appropriately.
needed help as they struggled to provide their neurology patients with continued care. As we formed the AAN Ukraine Crisis Response Work Group, we made their charge twofold. They needed to identify direct ways to help our member neurologists in Ukraine as well as identify a roadmap for how the AAN responds overall to future global conflicts. On Tuesday, April 5, 2022, the AAN hosted a Head Talks session at the AAN Annual Meeting called, “Crisis in Ukraine: How Can Neurology Help in Times of Global Conflict?” The session was moderated by Lyell K. Jones, Jr., MD, FAAN, chair of the AAN Ukraine Crisis Response Work Group. Panelists included myself, Ralph F. Józefowicz, MD, FAAN; Jerome H. Chin, MD, PhD, MPH, FAAN; and Aaron Berkowitz, MD, PhD, FAAN. The panel received questions and comments from the audience. Our hope is that the ideas shared during the Head Talks session can help inform the work group in this important task as they begin developing those guiding principles. Finally, we continue to meet with other neurology organizations to try to create an even greater community response now and for the future. We invite you to follow our progress at AAN.com/Ukraine. Postscript: Growing up, I had been told that my maternal grandparents came from Poland. But upon hearing these stories of the extraordinary work being done by my colleagues, my mother revealed that her parents’ city of origin was called Lwów. Many geopolitical changes followed but since the dissolution of the Soviet Union in 1991, Lwów, now called Lviv, became part of the newly independent Ukraine.
Orly Avitzur, MD, MBA, FAAN President, AAN oavitzur@aan.com @OrlyA on Twitter
We acknowledge that there are countries including Iraq, Syria, Yemen, Libya, and Palestine which have gone through their own serious crises. I would like to share the AAN’s thoughts on why we chose to address the current crisis in Ukraine and our plans to develop a pathway for when and how to address other global conflicts in the future. Almost immediately after Russia invaded Ukraine, we began hearing from our member neurologists in the region who
AANnews • May 2022
5
PRACTICE AAN Issues Position Statement on Neuropalliative Care The AAN issued ethical guidance for neurologists on providing palliative care to people living with neurologic diseases such as stroke, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The position statement was published in the March 7, 2022, online issue of Neurology ®, and was developed by the Ethics, Law, and Humanities Committee, a joint committee of the AAN, American Neurological Association, and Child Neurology Society. This revision is an update to previous AAN position statements. “Palliative care is a term that has become synonymous with hospice but it is actually a much broader practice,” said position statement author Lynne P. Taylor, MD, FAAN, of the University of Washington in Seattle. “Neurologists provide palliative care to peopleliving with life-altering neurologic illnesses not just at the end of life but throughout the course of a disease, improving lives with symptom control. This position statement outlines how clinicians, physicians, and advanced practice providers should provide palliative care for people living with neurologic disease, so they can have the best quality of life possible.” The AAN position statement says research has shown that palliative care is beneficial for people with serious illnesses, when provided early in the disease process, and may lead to longer survival. It says clinicians should discuss palliative care with their patients early to maximize the management of their symptoms and begin the process of advance care planning. The position statement provides care recommendations for: People who have had a stroke People with progressive neurologic diseases People with ALS Infants and children with serious neurologic disease
People with disorders of consciousness, when diagnosis and prognosis are uncertain
Taylor
People with irreversible disease who are still able to make decisions The position statement explains that communicating a person’s prognosis helps them understand their disease and empowers them to set care goals. It says conversations on care goals should take place regularly so that patients and their families are more prepared to make decisions as the disease progresses. Clinicians, patients, and surrogate decision-makers should engage in shared decision-making to achieve goals and to finalize a treatment plan. As a disease progresses, a person may change their treatment preferences, so advance care planning should be a dynamic process, revisited at regular intervals. “The AAN has seen the field of neuropalliative care continue to grow,” said President Orly Avitzur, MD, MBA, FAAN. “Neurologists have been at the forefront of providing palliative care to people with neurologic conditions. Our hope is this AAN position statement serves as an important tool for neurologists, providing important ethical guidance as they deliver the highest quality care to people with diseases of the brain, spine, and nerves throughout their lives.”
Use New Seizure Frequency Quality Measurement Set The AAN published a new seizure frequency quality measurement set in the April 4, 2022, online issue of Neurology®. This new measurement set supplements the 2017 epilepsy quality measurement set and contains one process measure and two outcome measures: Seizure Type, Frequency, and Time Since Last Seizure Recorded (process) Seizure Freedom (outcome) Tonic-Clonic Seizure Reduction (outcome) Process measures focus on the actions of health care professionals and evaluate whether these activities follow established evidence based clinical guidelines, care protocols, and best practices. Outcome measures address critical endpoints that represent the culmination of an episode of care, defined as the entire spectrum of care related to a particular disease, disorder or condition, from the initial assessment through the final stages of care. The Epilepsy Measure Development Work Group heard member feedback. After the two proposed outcome measures were posted
6
AANnews • May 2022
for public comment, the comments indicated that a process measure was also needed. The Seizure Type, Frequency, and Time Since Last Seizure Recorded process measure was then developed and a second public comment period was held. All three measures are included in the Axon Registry®. The measures will be reviewed in six months to monitor implementation efforts. View the executive summary published at Neurology.org and the full measurement set and tools on AAN.com.
Why Do Members Use AAN Neurology Compensation and Productivity Data? They use it for “determining compensation ranges.” And “to calculate FTE values,” “be competitive,” and “be more successful in recruiting.” Because it’s “superior and more powerful” than other available data. Your colleagues have found tremendous value using the data from the 2021 Neurology Compensation and Productivity Survey, based on responses from more than 4,000 AAN participants. This is the largest and most robust source of neurology data available, and with this essential resource, neurologists, advanced practice providers, and business administrators can find data needed to make informed decisions, analyze gaps, and identify opportunities. “We are a group of six employed neurologists who depend upon the NCP data to set reasonable RVU productivity targets with our employer,” said Michael Markowski, DO, FAAN, of Neurologists of Cape Cod. “In addition, we are reliant upon this data to ‘prove our worth’ and create an Markowski expected salary range during contract negotiations. Health care systems typically use MGMA data for their contract negotiations, however the details included within the AAN’s NCP report is superior and more powerful as it is based upon a much larger sample size of neurologists.”
Losey
For Travis E. Losey, MD, chair of neurology at Loma Linda University Faculty Medical Group, “The greatest value has been using this data for blended academic benchmarked salaries and wRVU productivity. We use this to calculate FTE values for external contracts and internal salary goals.”
Leeann Garms, CEO of Raleigh Neurology Associates, explained, “We are a large multi-specialty private practice who, like many, are continuously recruiting to meet the demands of the community we serve. We have used the AAN NCP survey data three times in the past several months Garms when determining compensation ranges for potential new physicians. This data has proven to be a powerful tool, providing us with neurology and
subspecialty specific data we can feel confident relying on to make these critical decisions. The ability to slice-and-dice the data by regions, practice types, practice sizes, and other criteria enable us to better understand the overall market and how we want to position ourselves within that market. We plan on continuing to use this data not only for recruiting new talent but also to ensure our structure supports retaining current talent.” “I have already used the new data to make a case to my dean about the salary we need to offer several different subspecialists to be competitive in our region,” said L. John Greenfield, Jr., MD, PhD, FAAN, program chair at University of Connecticut. “Our institution relies on… Greenfield AAMC averages for academic neurology by rank, which does not make any distinction between subspecialties. Having the data parsed in this way has helped me be more successful in recruiting and paying appropriately and provided increased confidence that the salaries we offer are competitive in the marketplace.” AAN members who completed the 2021 survey can access the dashboard for free (a $500 AAN member value). Easy-to-use filters and new data points allow you to sort by subspecialty, geographic region, and more. Members who did not participate in the survey may access the data for $500 ($1,500 for nonmembers). A complimentary executive summary is available at AAN.com/Benchmark to obtain a sneak peek at the insightful information they can use. Visit AAN.com/Benchmark today to start changing your practice for the better.
Neurology ® Podcast: PODCAST
20 Minutes Pack a Punch! Subscribe and download the latest podcast at Neurology.org/podcast
Follow and subscribe to our new podcast!
PRACTICE Open Office Sessions Keep Axon Registry Participants Connected, Informed
The AAN’s Axon Registry® is a quality improvement registry for neurology and a free US member benefit. The Academy uses multiple methods to interact with registry participants to answer questions and share new information, including monthly open office sessions, which Hill typically present a current Axon Registry topic and provide educational content. Examples of past and planned webinar topics include: MIPS submissions
An entertaining weekly podcast featuring conversations with neurology experts, celebrity advocates, and people whose lives are affected by brain conditions. Listen wherever you get your podcasts!
Updates for registry quality measures Quality measure guidance Telemedicine Transitioning technical vendor Registry dashboard demonstration Data Dictionary demonstration Open office sessions also provide registry users the opportunity to communicate with the Axon Registry staff directly. Following every presentation, staff hold a Q&A session to allow participants to ask questions about the presentation or anything related to the registry. Receiving direct feedback from participants helps make the Axon Registry an efficient and beneficial tool for all participating practices.
Daniel J. Correa, MD, MSc, FAAN, podcast editor and co-host
Audrey R. Nath, MD, PhD, podcast assistant editor and co-host
Share with your patients. BrainandLife.org/Podcast
Suchada “O” Hill, a practice administrator for Neurological Associates of Tucson, said “I appreciate the Axon Registry and the special speakers for providing support and continued education during our open office sessions. We learned and exchanged the new information, and I also love hearing feedback from other practices that may be facing the same issues. It gives you the sense of camaraderie knowing we are all working toward our common goals.” If you have any questions regarding the open office sessions or are interested in joining the Axon Registry, contact registry@aan.com or visit AAN.com/axon.
Peers Provide Expert Answers to Practice Questions The practice@aan.com email inbox is an efficient way to reach staff and member expertise on practice related topics such as payers, MIPS/MACRA, coding, and practice management. Staff experts respond within one business day and can seek the real-world expertise of the Practice Support Network, a group of 30 practicing neurologists and graduates of the AAN Practice Leadership Program, or the Business Support Network, a group of six business administrators in various practice settings. Below are some common questions that have come into the inbox recently.
PRACTICE MANAGEMENT Q: I am interested in starting telehealth services at my practice. What should I know about malpractice insurance and billing and reimbursement? A: The AAN has many resources to help you navigate the changing telehealth environment. With regards to malpractice insurance, most of our Practice Support Network found that their current carriers added telehealth coverage to their existing policies at the start of the pandemic. They recommended connecting with your current provider to see if that is still the case, if there are any additional fees associated with the coverage, and how the carrier handles out-ofstate coverage if applicable. One member recommended confirming with your carrier that they are bonded in the state in which you are practicing telehealth. For Medicare, many telehealth billing flexibilities are renewed every three months as the public health emergency (PHE) is renewed. These flexibilities include lifting geographic restrictions and paying the same as an in-person visit. The AAN is aware that without legislative action, critical flexibilities will expire when the PHE is terminated, making it difficult for practices to continue to treat patients via this valuable modality. The AAN is strongly advocating that some of these flexibilities continue beyond the PHE expiration to ensure there is no disruption in patient care and to be able to collect more data to add to the telehealth evidence-base. You can stay up to date on telehealth regulations and AAN’s advocacy efforts at AAN.com/Telehealth.
it is dependent on the contract specific to the payer. It is recommended to review the termination section of the contract to confirm the terms for that specific payer. It is also important to review your state laws regarding patient notification of your practice no longer accepting their health plan to avoid any issues with patient abandonment.
QUALITY PAYMENT PROGRAM Q: CMS makes changes to measures I can report in the Merit-based Incentive Payment System (MIPS) each year. How can I make sure I have the most updated information for 2022 Quality component reporting? A: Each year, the AAN develops updated resources related to the Quality Payment Program (QPP) and MIPS, including identifying measures and activities that are most relevant to neurologists that year. The AAN’s Quality Payment Program webpage just refreshed its resource on how to “Navigate the Quality Component of MIPS” which includes 2022 neurology measures available in MIPS, including measures in the Axon Registry ®. For the Improvement Activities component, the AAN continues to offer the resource on “Improvement Activities for Neurologists to Consider” that can help practices determine what practice improvement activities neurologists can select or may already be participating in and can attest for credit in MIPS. Members can find these resources at AAN.com/qpp. Additionally, the Centers for Medicare & Medicaid Services (CMS) has a tool to search and navigate quality measures by specialty at qpp.cms.gov.
PAYMENT POLICY Q. My practice is considering stopping our commercial payer contracts. Will my practice be reimbursed in-network under a grace period of 90 days after our termination with the payer? A. If there is any grace period for in-network coverage after the termination of a contract with a commercial payer,
AANnews • May 2022
9
PRACTICE Neurology: Education Journal Announced José G. Merino, MD, MPhil, FAHA, FAAN, editor-in-chief of the flagship journal Neurology®, said of the new publication, “There is a need for a rigorous journal that publishes robust research on neurologic and medical education. This journal fills that gap. Through it, the AAN serves the neurologic academic community. It will focus on research that will help better educate the future generations of neurologists.”
Strowd is a board-certified neurologist, fellowship trained neuro-oncologist, and educator at Wake Forest School of Medicine. He is assistant dean for Undergraduate Medical Education and director of the Health Professions Education Institute at Atrium Health Strowd Wake Forest Baptist. Strowd completed his MD and MS degrees at Wake Forest and Master of Education in the Health Professions at Johns Hopkins School of Education. He is an accomplished education researcher. He has received grant funding specific to education research from Alpha Omega Alpha, the American Board of Psychiatry and Neurology, and the AAN. Of his over 100 peer-reviewed research articles, more than 30 are specific to medical education including publications in Teaching and Learning in Medicine, Medical Teacher, MedEd PORTAL, Clinical Teacher, BMC Medical Education, Neurology, and other influential journals. He is former associate editor for Medical Education Online. His many teaching awards and recognitions include the SGEA Innovation in Education Award in 2019 and the inaugural AAMC M. Brownell Anderson Award in 2020.
Merino
The newly appointed editor for Neurology: Education is Roy E. Strowd III, MD, MEd, MS, FAAN, previously the section editor for the Resident & Fellow Section of Neurology, where he has managed the education portfolio for the journal. “Neurology has a strong tradition of phenomenal teachers and a commitment to great education,” said Strowd. “Now as much as ever, our field needs outlets to develop, disseminate, and promote evidence-based teaching practices that help us train a competent, fulfilled, and inquisitive current and future neurology workforce. Neurology: Education is an extremely exciting step in this direction. The journal will publish original education research articles, reviews, and editorials on evidence-based teaching methods and curriculum innovations. I hope that this journal can help provide a forum for the academic community to exchange ideas, discuss new innovations, and highlight advances that will enhance neurologic and neuroscience teaching and training. The future of our field is bright for authors, readers, educators, trainees, and our patients.”
While designed for clinical educators, the journal will be free to authors and readers worldwide. Neurology: Education will be a continuous online-only journal with issues compiled two to four times per year. To submit a manuscript, visit submit.neurology.org and select the “Neurology: Education” manuscript category. For more information about the publication, visit NPub.org/NE.
1, Volume
A peer-reviewed
A peer-re
ical and
ld of med
l in the fie
urna viewed jo
continued from cover
journal in the field
of medical and biom
edical education
AANnews • May 2022
research
research
ARCH
2
E
Neu
EDUCATION RESE
10
1, September 202
Neurology.org/N
rg/NE rology.o
n l educatio
biomedica
Volume 1, Number
22
ember 20
1, Sept Number
Effect of Scheduled Faculty Modeling on Student Bedside Sk g on ills Exposure and in el SEARCH d RE o Lea N M rni IO y ng lt e14 u EDUCAT ac F d le d hedu xposure an Effect of Sc de Skills EEDU CATION RESEARC edsi H Student B Poor Interrater Re e14 g liability in Evaluati in rn ea L ng the Neurology Cli ingnical Skills at lu SEARCH va RE E N Ex IO am in tion e22 EDUCAT ability ina
EVENTS May 26 Is Early Registration Deadline for New Summer Conference continued from cover
Expert faculty Anastasia Zekeridou, MD, of Mayo Clinic in Rochester, MN, and Stacey Clardy, MD, PhD, FAAN, of the University of Utah, will direct the two-day program with highlights to include: Opening and closing keynote addresses Panel Q&A Posters Exhibit hall Case Studies
Year in review session led by Nicole Beaton Sur, MD, of the University of Miami, with talks on headache, multiple sclerosis, epilepsy, dementia, movement disorders, and stroke
July 15–16, San Francisco
Visit AAN.com/SummerConference to learn more and to secure your early registration savings by May 26.
Autoimmune Neurology Abstracts Due May 3 Abstracts showcasing the latest autoimmune neurology research are now being accepted until 11:59 p.m. CT on May 3. Abstract fees are $50 for AAN members, $100 for nonmembers, and free for students and residents. Visit AAN.com/SummerConference to learn more and to submit.
STAND OUT FOR YOUR ACHIEVEMENTS Apply for the prestigious Fellow of the American Academy of Neurology designation.
AAN.com/FAAN
EVENTS
'Great Neuro Reunion' Is Celebrated in Seattle
After two years apart, the AAN’s 74th Annual Meeting brought together more than 8,000 excited neurology professionals for six days of education, science, and camaraderie. Even with masks on, everyone was smiling!
AANnews • May 2022
13
ADVOCACY
Capitol Hill Report Capitol Hill Report presents regular updates on legislative and regulatory actions and how the Academy ensures that the voice of neurology is heard on Capitol Hill. It is emailed to US members twice monthly and is posted at AAN.com/view/HillReport. Below are some recent highlights.
Latest Advocacy News On April 7, the Centers for Medicare & Medicaid Services (CMS) released the final National Coverage Determination (NCD) for aducanumab and other monoclonal antibodies (mAb) directed against amyloid for the treatment of Alzheimer's disease. The AAN's advocacy had a substantial impact and is reflected in key changes to the final NCD, as well as CMS' extensive citation of the AAN throughout. Key changes include: a modification so that trials are not solely limited to the hospital outpatient setting, a commitment from CMS to quickly reconsider the NCD if a mAb product has answered the CED questions with quality evidence, and deference to CED investigators in determining key elements of study design. The AAN's full summary of the NCD can be found on page 15. On April 4, the AAN submitted a letter to CMS conveying key concerns and providing recommendations relating to changes to split (or shared) billing policy set to go into effect in 2023. The AAN believes that if implemented, the changes would have a chilling effect on physician-led team-based care. In the letter, we argued that both time and medical decision making (MDM) should be allowed to be used to determine the billing practitioner and offered recommendations relating to determining the substantive portion of MDM for the purposes of billing. The Department of Health and Human Services Office of the Inspector General released a new report examining the use of telehealth services in Medicare during the first year of the pandemic, declaring that telehealth was critical during this time period for Medicare beneficiaries.
Issue in Focus Thank you for the strong outpouring of feedback and support during this year’s Annual Meeting of the American Academy of Neurology in Seattle. Advocacy leaders led courses throughout the week to share how the AAN is advocating for you—and to hear critical feedback about challenges facing neurology practices across the county. Additionally, AAN members contributed over $65,000 to the AAN’s political action committee
14
AANnews • May 2022
BrainPAC, the highest figure in four years. This infusion of feedback and resources is well timed, as Congress has been extremely active already in 2022 on the AAN’s priorities, including: Key Physician Mental Health Bill Passes: The Lorna Breen Health Care Provider Protection Act, which establishes grants and requires other activities to improve mental and behavioral health among health care providers, was signed into law by President Biden on March 18. Regulatory Relief: The AAN helped secure the support of a majority of representatives for legislation to reform prior authorization in Medicare Advantage. Addressing High Drug Costs: The Academy published an op-ed in a national publication highlighting AAN’s support for lowering drug costs. Health Care Workforce Hearings: Two congressional hearings focused on strengthening the health care workforce and the role of international physicians on the health care workforce. The AAN submitted a statement for the record and met with legislative staff leading up to the hearings. Telehealth: Congress extended Medicare telehealth flexibilities for 151 days following the end of the public health emergency (PHE). Government Funding: Congress enacted historic levels of funding for federal medical research for fiscal year 2022, including significant increases to the National Institutes of Health and the BRAIN Initiative, and $1 billion for the new AAN-supported ARPA-H program. Extensive Feedback to Republican Leadership: The AAN submitted comments for the GOP Healthy Future Task Force request for information. The eight-page document highlighted a majority of AAN priorities and will be used by Republican leadership. Veterans: Thanks to persistent advocacy by the AAN, Congress urged the Department of Veterans Affairs to "increase its investment to maintain and expand existing centers of excellence within VA dedicated to neurological conditions."
PRACTICE CMS Finalizes Limited Coverage of Aducanumab On April 7, the Centers for Medicare & Medicaid Services (CMS) released its final National Coverage Determination (NCD) for monoclonal antibodies (mAbs) directed against amyloid for the treatment of Alzheimer’s disease (AD). The AAN has been engaged with regulators and other stakeholders on the issues surrounding aducanumab (brand name Aduhelm) since prior to the drug’s FDA approval in June 2021. During the comment period for this NCD, the AAN met with CMS on several occasions and provided the agency with written comments. The AAN’s advocacy had a substantial impact on the final NCD as seen in a number of key changes to the final NCD, and CMS’ extensive citation of the AAN including the recent Evidence in Focus report. CMS has finalized the following policies: Use of coverage with evidence development (CED) to further study aducanumab and future drugs within the same class. The CED requirements account for multiple products that are currently in various stages of the FDA approval process. Products approved based on a change in a surrogate endpoint may be covered in a randomized controlled trial or trials supported by the NIH. Products approved based on a direct measure of clinical benefit may be covered in CMS approved prospective comparative studies for beneficiaries that are similar to patients in that drug’s pivotal trial. Use of mAbs directed against amyloid for the treatment of AD provided outside of a FDA approved randomized controlled trial, CMS approved studies, or studies supported by the NIH, are nationally non-covered. The setting at which trials can be held is not restricted. Study protocols submitted for approval must include a description of the multidisciplinary team and optimal management of patients as well as the study sites with clinical expertise and infrastructure to provide treatments consistent with safety monitoring protocols.
CMS approved studies must include a study population whose diversity of patients is representative of the national population with mild cognitive impairment (MCI) due to AD or mild AD dementia. Allowance for one PET scan for amyloid in the patient’s lifetime to confirm amyloid positivity. This NCD realizes many of the key elements of the AAN’s advocacy including limitation of coverage to patients with MCI or mild AD, further clinical trials to confirm clinical benefit, coverage of PET to confirm amyloid positivity, and more inclusive trial data to reflect the diverse patient population. Additionally, the final NCD includes several positive changes when compared to what was initially proposed stemming from the AAN’s advocacy. These include a modification so that trials are not solely limited to the hospital outpatient setting, a commitment from CMS to quickly reconsider the NCD if a mAb product has answered the CED questions with quality evidence, and deference to CED investigators in determining key elements of study design. Find more information and resources on the Aducanumab Resources page at AAN.com/Aducanumab.
Promotion of maximum flexibility for investigators to conduct a wide range of study designs to assess benefits and harms in special populations, as well as patients with various comorbidities who were excluded from patient populations in RCTs designed for FDA approval.
AAN.com/Aducanumab AANnews • May 2022
15
EDUCATION Continuum Spotlights Epilepsy Epilepsy is examined in the current issue of Continuum: Lifelong Learning in Neurology, and Guest Editor Nathalie Jetté, MD, MSc, FRCPC, CSCN(EEG), FAAN, FAES, FANA, highlighted some of the new information available in this issue. Seizures and Epilepsy in Childhood Maria Gogou, MD, PhD Judith Helen Cross, MBChB, PhD
“This issue features the latest epilepsy-related advances and topics including the up-to-date treatment of status epilepticus, imaging modalities, pregnancy outcome data, management of psychiatric comorbidity, and clinical features of genetic epilepsy syndromes. Readers will also learn about scoring systems to aid in the identification of autoimmune encephalitis and autoimmune epilepsy.”
Neuropsychiatric and Cognitive Comorbidities in Epilepsy Marco Mula, MD, PhD, FRCP, FEAN Honor Coleman, MPsych, PhD Sarah J. Wilson, PhD, FAHMS, FASSA
Content for this issue includes:
Approach to the Medical Treatment of Epilepsy Francesco Brigo, MD Anthony Marson, MBChB, MD, FRCP
Evaluation of First Seizure and Newly Diagnosed Epilepsy Elaine Wirrell, MD, FRCP(C), FAAN EEG Essentials William O. Tatum IV, DO, FAAN, FACNS, FAES
Update on Antiseizure Medications 2022 Bassel W. Abou-Khalil, MD, FAAN
Neuroimaging of Epilepsy Samuel Lapalme-Remis, MDCM, MA, FRCPC Dang K. Nguyen, MD, PhD, FRCPC
Surgical Treatments for Epilepsy George W. Culler IV, MD Barbara C. Jobst, Dr Med, PhD, FAAN
Genetic Epilepsy Syndromes Kenneth A. Myers, MD, PhD, FRCPC, CSCN(EEG)
Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus Eugen Trinka, MD, MSc, FRCP Markus Leitinger, MD, MSc
Autoimmune-associated Seizures Lisa Gillinder, MBBS, FRACP Jeffrey Britton, MD, FAAN
This issue includes a postreading self-assessment and test with the opportunity to earn up to 20 AMA PRA Category 1 Credits™ toward Self-assessment CME.
Women’s Issues in Epilepsy Esther Bui, MD, FRCP(C)
m u u n i t n Co LIFE
G L ON
LEA
R NI
NG
IN
epsy l i p E
R N EU
OL O
®
GY
N (E AN CSC D, FA P C, IS , M S C , F R C LE W ,M E N L. T É , M D TE V JE T F: S E IE LI H A N -C AT H O R -I R: N E D IT D IT O ST E GUE
E G ),
FA A
N , FA
ES,
FA N
A
APR
IL 2
022
V O L.
28
N O.
2
Until June 30, 2022, subscriptions and renewals to Continuum® are 15-percent off the already low AAN member rate. AAN members pay just $339 per year for a subscription to Continuum® and Continuum® Audio. Subscribe now by contacting Wolters Kluwer at (800) 361-0633 or (301) 223-2300 (international) or visit shop.lww.com/continuum and enter code WMQ074AA at checkout to receive the discounted price. AAN junior member who are transitioning to neurologist memberships are eligible to receive a 60-percent discount on the already low member rate for the Continuum® and Continuum® Audio subscription.
CON
16
AANnews • May 2022
Jetté
T IN U
UM JO
URN
A L.C
OM
RESEARCH Rost Covers Top Science with Media in Press Conference Natalia S. Rost, MD, MPH, FAHA, FAAN, chair of the Science Committee, spoke to reporters during a press conference on exciting research from researchers Nancy J. Newman, MD, FAAN, of Emory University School of Medicine in Atlanta; Douglas J. Weber, PhD, of Carnegie Mellon University in Pittsburgh; and Natalia S. Rost, MD, MPH, FAHA, FAAN Joanna Hellmuth, MD, MHS, of the University of California, San Francisco.
Nancy J. Newman, MD, FAAN
Douglas J. Weber, PhD
Joanna Hellmuth, MD, MHS
Newman’s abstract is titled "The Phase III REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON)." Weber presented on "Long-Term Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis: Results of SWITCH, a First-in-Human Study." Hellmuth’s abstract is "Cognitive Symptoms After Mild SARS-CoV-2 Infection Associate with Higher Levels of CSF Immune Activation and Immunovascular Markers." A recording of the press conference, which was held on March 29 via video conference, is available on the AAN YouTube channel at youtube.com/AANChannel.
m is the ..?” “Is I…?” ow ” r o e d f a t d I…? s the de ere a co ” “Wha ” “What line for. should“When i ad t form I…?” tf n i “Is th yer…? e…? e a e d h h a a W r...?” o l m is the “Wh “W o I… p l d ” e e t ? w h o e f “Can t ho can “When er…?” ?” “Ho ayer… ow d H e y p ” r…? I…?” “Wdo I…?” n the pa e best…Can the st…?” “ the pay? e h ould ” “How …?” “Ca hat is t for…?” “ is the b ?” “Cane best… ” rpractice W ode at e for… t is th or…? o “ f h ” e st…?coGot ? W d f “ a … re a c d e ” h e o ? d c a W m o a “ … e ere anmanagement tell “Is th ell me there e…?” ere a c l me…?” “ c th n tel ?” can t ?” “Is tell m . o . .?” s . . h I r . “ r o W ine f . a o ” . o f c . h e or ho can for...? Who f “W n W i l “ questions? ” e d ? ” n adl I… “ i e a ? l … “W eadlin I…?” he de uld I ad d ” e d ? d l e t u o h d … e d t l I s o h th oanswers ou hen i orm s hen is m ld is the isGet h u s n h e m ?” “W hat f ” “W n r or e f o h f Wh t foin t rm sone t a W ? W a h “ business “ h I… “H … Wha do I…?” …?” “W How do yer…?” ow do I r…?” “West…?” c a e “ask. H p y “ ” e b here a a ow e day. e ? ” ayer sJust h p t h ? p t … e s t an best… an th e at i ?” “Is t rm sh C b h “ e an ths practice@aan.com ” C W th or…? the r…?” “ …?” “ e for... hat fo ha i s i t f a t “W ?” “W Wh a code ” “Wha ode fo tell me eadlin ” ? … ere me…? here a c ho can is the d payer…tell me…ow do I e e ll t n n H Practice Email Ad—Half Page Horizontal> AN Placed in AANnews 8.25 x 5.25 +0.125 bleed, 4C
MEMBERSHIP
IDEAS Programming Gets Strong Interest from Annual Meeting Attendees Inclusion is the reason the AAN was founded. To be an organization that is the home for all neurologists. It is what makes us stronger. To support our goal of being a fully inclusive, deliberately diverse, and anti-racist organization and our core values of Inclusion, Diversity, Equity, Anti-racism, and Social Justice (IDEAS), we are excited to share progress and updates with you. The Annual Meeting in Seattle included more than 40 IDEASrelated offerings including programs, displays, and posters. As part of its ongoing effort to explore ways to eliminate the disparity gap in neurology health care, the Academy held its second annual Health Care Equity Symposium. The session featured the Cheryl A. Jay Keynote Lecture by LaShyra “Lash” Nolen, an MD candidate at Harvard Medical School, as well as presentations on Disparities in Dementia by Liliana Ramirez Gomez, MD, and Disparities in Stroke by Olajide A. Williams, MD, MS. Another highlight was a panel discussion of AAN members and staff on the conception, development, and implementation of the AAN's new online Anti-racism Education Program—a training program designed by neurologists, for neurologists. The event provided an opportunity for AAN members to learn about how to best use the program and how to integrate anti-racism in their personal lives, clinical practices, and health systems. “We are encouraged by the participation and attendance in the Health Care Equity Symposium and the AAN Anti-racism Education Program Informational Session,” said Jeffrey C. McClean II, MD, FAAN, course director for the symposium and chair of the Inclusion, Diversity, Equity, Anti-racism, and Social Justice Subcommittee. “The numbers speak for themselves: our members are eager to engage in IDEAS work across the Academy and within their own institutions.” In addition, 10 scholarship recipients were recognized this year for their desire to learn more about disparities and work toward equity in neurologic care. This yearlong scholarship
The AAN Anti-racism Education Program Informational Session panel featured (from left) Jeffrey C. McClean II, MD, FAAN; Nimish A. Mohile, MD, FAAN; Ralph L. Sacco, MD, MS, FAHA, FAAN; Jessica Isom, MD; and Sara Dawit, MD.
20
AANnews • May 2022
program kicked off at the Annual Meeting McClean Mohile with the recipients attending a full day of symposium programming, including a specialized workshop on bias. Over the next year, they will participate in additional workshops aimed to educate in more detail about disparities and mitigation strategies. The program is overseen by a physician work group led by McClean and Morgan Jordan, DO. “It’s amazing to note the diversity of our speakers, our session topics, and our attendees,” said Nimish A. Mohile, MD, FAAN, chair of the Diversity Officer Subcommittee and Education Committee. “There used to be a time when you could easily attend all of the diversity-related programming at the Annual Meeting. Now—it’s impossible to hit it all. If you missed anything, be sure to check out the Annual Meeting On Demand for IDEAS-related content.” For more about the AAN’s efforts around health care disparities and IDEAS, visit AAN.com/IDEAS.
We Need Your Feedback! Please complete a brief member survey regarding our efforts in Inclusion, Diversity, Equity, Anti-racism, Social Justice (IDEAS). To take the survey online, visit AAN.com/IDEAS.
Members of the IDEAS Subcommittee visited with students and residents at the IDEAS display wall during the IDEAS Meet and Greet.
Leadership Program Opens Doors to Engagement When asked about his experience with the AAN’s Emerging Leaders Program, 2017 graduate Beau Nakamoto, MD, PhD, MBA, FAAN, is quick to respond that “the biggest impact it had was that it opened the door to engage with the AAN and its members.” Rather ironically, it was a subtle act of engagement that brought the Emerging Leaders Program to Nakamoto’s attention to begin with. “To be honest, it was the AAN staff who piqued my initial interest in the program,” he explained. “I did not renew my AAN membership after residency and by chance I happened to reach out to the ‘Contact Us’ link on the AAN website for assistance. I don’t remember what the issue was, but I still remember how the AAN staff member who helped me made me feel: special, like I mattered. Based on this, I started to look at ways to re-engage with the AAN. The rest is history.” History, indeed. Since graduating just a few years ago, both Nakamoto’s career and his engagement with the AAN have taken off like a rocket. “The Emerging Leaders Program was pivotal for my career. I doubt I would have been able to catapult my career so quickly without participation in this program.” Nakamoto is now vice chair of the AAN’s Leadership Alumni Subcommittee and member of the AAN Membership Engagement and Leadership Engagement Committees where he has “a network of AAN members from academic universities who I collaborate with, can ask advice on complicated neurological cases, and can reach out to for recommendations for academic promotion.” Along the way he has developed deep friendships with neurologists nationwide, as well as AAN staff members—all of whom he is grateful to have in his life. “I have significant more joy and work-life integration in my life, all from participation in this program,” he said. “I have found a tribe of like-minded people, all of whom value learning and growing professionally.” In terms of his professional growth, Nakamoto now serves on the Board of Directors for Hawaii Pacific Health, one of the largest health care providers in the state, and recently transitioned into a career in medical informatics. “I have obtained an MBA, become certified as a physician executive, became an FAAN, became a Fellow in the American Association of Physician Leaders and American College of Health Care Executives, served as the director of the Neuroscience Serviceline, served as director of a stroke program, and am looking to apply for professor at the University of Hawaii,” he said. Nakamoto’s hunger for engagement has even led him to take up advocacy, donating to the BrainPAC
and making himself available to meet with senators and his local representatives on important AAN-related issues. In speaking about the AAN’s investment in providing leadership opportunities for members, Nakamoto said, “It is wonderful to see the movements being made to engage all its members and expand leadership opportunities to all its members. The AAN has been strategic as far as focusing on making sure that its leaders are representative of the general membership from academic to solo practitioners and making sure disparities based on gender, ethnicity, and gender identities are addressed. I have no doubt that at the end of this yellow brick road the AAN will have an army of engaged members.” In reflecting on his experience in general, Nakamoto expressed great appreciation for the importance of never losing sight of the personal touches that make each and everyone feel special, valued, and important. “The gestures of gift baskets for members who serve; the social events when we go to committee meetings—all not necessary, but definitely noted. I hope we never lose sight of that all our members are special and all of us want to feel like we belong and are working to contribute to something greater than ourselves.” And now the ripple effect of an AAN staff member making Nakamoto feel special when he reached out for help will only continue. “Am I grateful for the Emerging Leaders Program? Yes. That is an understatement.” This Emerging Leaders Program is designed to identify, engage, and mentor talented early-career members who have the disposition to lead and are interested in future roles within the AAN and the field of neurology. Learn more at AAN.com/ELP.
Thank you to the organizations supporting this program in part:
AbbVie Alexion, AstraZeneca Rare Disease Alnylam Pharmaceuticals argenx Bristol Myers Squibb Sanofi Supernus Pharmaceuticals, Inc. UCB
Learn more at AAN.com/ELP AANnews • May 2022
21
MEMBERSHIP 2021 Successes Touted at AAN Business Meeting The annual Business Meeting of the American Academy of Neurology was held yesterday, and the 2021 activities and finances were highlighted by President Orly Avitzur, MD, MBA, FAAN; CEO Mary E. Post, MBA, CAE; and Treasurer Charles C. Flippen II, MD, FAAN. After convening the meeting, Avitzur reviewed the Academy’s vision, mission, and core values. She cited the AAN as the world’s largest professional association of neurologists with 38,000+ members, including thousands of members who serve in 6,800 volunteer positions, as well as 200 staff. She spoke of progress on her presidential platform, the impact of COVID-19, global outreach efforts, and other major initiatives. Avitzur also highlighted newly established committees and subcommittees and their efforts: Academic Committee; IDEAS (Inclusion, Diversity, Equity, Anti-racism, and Social Justice) Subcommittee; Committee on Public Engagement, which guided the development of the new Brain & Life podcast; Telehealth Subcommittee; and Wellness Subcommittee. Treasurer Flippen outlined financial results for 2021, with AAN consolidated operating revenues of $53 million and $46.4 million in expenses. From a financial standpoint, 2021 surpassed expectations amid the many uncertainties caused by the pandemic. Leading the way on the revenue side were royalties and publications with 44 percent of income, followed by membership dues, conferences and education, and grants
22
AANnews • May 2022
and gifts. Education activities made up 24 percent of expenses, followed by administrative, advocacy, membership, grants and awards, and publications. In all, 79 cents of every dollar of revenue was used to support member products and services. CEO Post called out the Academy’s continued record membership growth to more than 38,000 (including members in arrears). The AAN has 92 percent US market share of neurologists, based on 2020 data, and now has more than 1,900 advanced practice provider members as well as its highest membership for students (6,100+) and juniors (5,400+ residents and fellows). The CEO also spotlighted accomplishments in education, publications, advocacy, and other initiatives. To learn more about last year’s successes, read the AAN 2021 Annual Report at AAN.com/AnnualReport.
Apply by May 18 for AAN Leadership Development Opportunities continued from cover
the AAN is committed to investing in members now to develop tomorrow’s leaders. The AAN is committed to building leadership reflective of our diverse member and patient demographics. This empowering and inspirational program provides a meaningful developmental experience that fully engages members from underrepresented neurology groups. This program is designed to identify, engage, and mentor talented early-career members who have the disposition to lead and are interested in future roles within the AAN and the field of neurology.
A unique opportunity designed specifically to identify and engage US neurologists in a solo or small practice who are interested in helping to shape the future of neurology with the AAN and their communities. The program’s convenient format provides high-quality development training while accommodating the demanding schedules of busy practitioners. Visit AAN.com/lead to browse the programs, application qualifications, and participant expectations and apply before the May 18 application deadline—and be sure and share these opportunities with colleagues who you think would be a good fit for this extraordinary leadership development opportunity.
Careers.AAN.com
Visit the AAN’s Neurology Career Center to view hundreds of additional jobs and sign up for customized, confidential notifications when positions of interest are added. Director, Neuro-Intensive Care—Rhode Island Hospital— Providence, Rhode Island Brown Neurology and Rhode Island Hospital are seeking a full-time physician scientist and academic leader to serve as Director of the Neurocritical Care Unit (NCCU) and Division Chief of Neurocritical Care within the Department of Neurology. The Division of Neuro Critical care at Brown University (Brown Neurology) is seeking to hire a faculty member who will work as a full-time academic investigator, interested in pursuing or continuing an academic, funded career in neuro-critical care. The NCCU is an established, state-of-the-art 18-bed neurological/neurosurgical critical care unit located at Rhode Island Hospital, the only Comprehensive Stroke Center and Level 1 Trauma Center in the state of Rhode Island, with a large catchment area that also includes Southeastern Massachusetts. An ideal candidate will have a track record of external research funding and an interest in further expanding the division’s robust research program. Preexisting independent funding is preferable, but candidates with mentored awards who are close to achieving independence are also welcomed to apply. In addition to assuming the role of Neurocritical Care Division Chief, the successful candidate will also assume the role of Director of the NCCU, which will entail leading the neurocritical care clinical program and a group of experienced neurointensivists in our large, multi-hospital healthcare system. This position involves working closely with experienced colleagues and on-site staff, including advanced practice providers, neuroscience nurses, and research staff, with active participation in multiple clinical trials. The successful candidate should have a track record of administrative experience, preferably within a similar academic neurocritical care setting. The successful candidate should be eligible for appointment as an Associate Professor or Professor at the Warren Alpert School of Medicine at Brown University. Inpatient service time will include attending on the NCCU along with the rest of the neurocritical care faculty. The candidate should be committed to advancing healthcare equity in neuro-critical care. This is an exciting opportunity to join our team of accomplished medical professionals. Brown Neurology is a faculty practice group affiliated with the Warren Alpert Medical School at Brown University and its diverse academic resources. We will provide consistent mentorship, institutional
support, and a path to promotion. Inquiries can be sent to Stacy Whirl (swhirl@lifespan.org). With over 40 physicians, Brown Neurology is a large physician group based in Rhode Island and offers competitive salary and outstanding benefits. We at Brown Neurology also value a diverse and talented workplace. We serve a diverse patient population ranging from all over Southern New England, including those from underserved areas, and we seek colleagues who strive to better understand systemic racism as it affects patient care and our academic institutions. All who are eligible are welcome to apply. Visit us at https://brownphysicians.org/ brown-neurology/. EOE/M/F/Vets/Disabled Practice Outpatient Neurology in The Most Popular Tourist Destination in the US—Synapse Neurology—Clermont, Florida Enjoy practicing in one of the MOST POPULAR travel destinations in the United States. From science programs to music festivals, bowl games and of course home to Mickey and Minnie Mouse, this City Beautiful attracts people from all over world where you can work and play. Synapse Neurology, located in Clermont, 26 miles west of Orlando, is actively recruiting a Board-Certified General Neurologist or a fellowship trained neurologist to join the well-respected, established, and busy practice. This is a rapidly growing practice. Opportunities exist to develop subspecialty practices in a variety of areas, including, but not limited to, movement disorders, neuromuscular, headache, cognitive neurology, MS and epilepsy. Practice Details And Features Include: General Neurologist, Nurse Practitioner, 5200 square foot modern office with electronic EMR, Clinical Neurophysiology Lab with EMG and EEG, In office Infusion Center, Botox Therapy, Outpatient Practice. Compensation and Benefits: 300K + and Full benefits package. Email administrator@ synapseneurology.com to apply. Full-Time Neurologist Opportunity in a Charming Community 75min from Chicago—Morris Hospital & Healthcare Centers—Morris, Illinois Morris Hospital & Healthcare Centers is 1 of 14% of USA hospitals with a 5-star rating for Overall Hospital Quality from CMS. Help us continue to drive the quality-care we deliver by joining a reputable, well-established practice that’s been in operation for over 20 years with a genuine need for an additional full-time Neurologist. Neurology Practice: Build out
your sub-specialization with a great team who offer diverse experience, Bread and butter neurology with great variety, plus APP support in office & great resources in the area, Strong referral patterns with 23 PCPs and facilities around our service area, Outpatient clinics conveniently located in Morris and 15min away in Channahon. Morris Hospital: Primary Stroke Certified and Level II Trauma Center, plus we offer an accredited Sleep Center, Recently remodeled and expanded EEG/EMG rooms, Concussion Management Program featuring multi-disciplinary approach with ImPACT providers, Serves a population of 170,000 residents with 37 medical specialties in the far southwest suburbs of Chicago. Compensation: Excellent market competitive compensation and benefits package, Production compensation, plus physician-driven quality compensation, Moving Bonus, Ongoing loan repayment. Morris, Illinois: Beautiful safe neighborhoods—some with backyard accessible waterfronts, Highly rated local public and private schools plus easy commute to Illinois’ most prestigious colleges and universities, 60 miles to Chicago and short drive to Chicago’s suburbs, Many Fortune 500 employers in Morris and the surrounding area including Grainger, BMW, Proctor & Gamble and Costco. For more information, please contact Jennifer Goodwin, Manager of Physician Recruitment & Relations at (815) 705-1470, texts/calls also welcome at (630) 347-7539 or email her at jgoodwin@morrishospital.org AANnews® Classified Advertising
he AAN offers a complete package of print, T online, and in-person recruitment advertising opportunities. Visit careers.AAN.com for all AAN options, rates, and deadlines. d copy for the July 2022 print edition of AANnews A must be submitted by June 1, 2022. The same deadline applies to changes/cancellations. he American Academy of Neurology reserves the T right to decline, withdraw, or edit advertisements at its discretion. Every care is taken to avoid mistakes, but the responsibility for clerical or printer errors does not exceed the cost of the ad.
AANnews • May 2022
23
DATES & DEADLINES MAY 2022
JUNE 2022
SUN
MON
TUE
WED
THU
FRI
SAT
1
2
3
4
5
6
7
SUN
MON
TUE
JULY 2022
WED
THU
FRI
SAT
1
2
3
4
SUN
MON
TUE
WED
THU
FRI
SAT
1
2
8
9
10
11
12
13
14
5
6
7
8
9
10
11
3
4
5
6
7
8
9
15
16
17
18
19
20
21
12
13
14
15
16
17
18
10
11
12
13
14
15
16
22
23
24
25
26
27
28
19
20
21
22
23
24
25
29
30
31
26
27
28
29
30
MAY 1
JUNE 1
Application Deadline: UCNS Behavioral Neurology & Neuropsychiatry Certification UCNS.org/BNNPcertification
Deadline: UCNS Fellowship Training Accreditation UCNS.org/Accreditation
Application Available: UCNS Neuroimaging Certification UCNS.org/NIcertification
Deadline: UCNS Autonomic Disorders Certification UCNS.org/Adcertification
MAY 3
Abstract Submission Deadline: AAN Summer Conference: Autoimmune Neurology and Neurology Year in Review AAN.com/SummerConference
17 24
31
18
19
20
21
22
23
25
26
27
18
29
30
JULY 15–16
AAN Summer Conference: Autoimmune Neurology and Neurology Year in Review AAN.com/SummerConference
JUNE 23
Advance Registration and Hotel Deadline: AAN Summer Conference: Autoimmune Neurology and Neurology Year in Review AAN.com/SummerConference
MAY 14
Deadline: 2022 Annual Meeting Registration Upgrade AAN.com/AM
MAY 18
Application Deadline: Emerging Leaders, Practice Leadership, and Diversity Leadership Programs AAN.com/Lead
MAY 23–24
Neurology on the Hill AAN.com/NOH
MAY 26
Early Registration Deadline: AAN Summer Conference: Autoimmune Neurology and Neurology Year in Review AAN.com/SummerConference
AANe-news. Because Your Time Is Valuable. Sent to your email address the second and fourth Wednesday of each month, AANe-news™ delivers the latest top headlines and resources from the Academy so you can quickly scan and connect directly with the information you need to know. Another members-only solution from your AAN.